Pfizer Sees Emergency Use Filing For COVID-19 Vaccine After US Election
On Friday, Pfizer Inc said it may file for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, making it unlikely a vaccine will be available before US elections as President Donald Trump has promised. The regulatory filing for the vaccine could come as soon as safety data is […]
Continue Reading